| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC0314 |
| Trial ID | NCT02775292 |
| Disease | Solid Tumor |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | NY-ESO-1 TCR-T cells |
| Co-treatment | Nivolumab |
| HLA | HLA-A*02:01 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | NY-ESO-1 TCR Engineered Adoptive Cell Transfer Therapy With Nivolumab PD-1 Blockade |
| Year | 2016 |
| Country | United States |
| Company sponsor | Jonsson Comprehensive Cancer Center |
| Other ID(s) | 15-001433|NCI-2016-00201|R35CA197633|15-001433|K12HD000850 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||||
|
|||||||||||||||